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them a candidate for use in bone tissue engineering applications. The objective of this study was to validate
the ability of dermal fibroblasts to express gene and protein markers of osteoblastic differentiation and to
explore their potential, in combination with biomaterial scaffolds and signaling factors, for use in bone tissue
engineering.
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Induction of Osteoblast Differentiation Markers in Human Dermal 
Fibroblasts: Potential Application to Bone Tissue Engineering 
Christopher K. Hee and Steven B. Nicoll 
Abstract-Tissue engineered constructs have the potential to 
be used as replacements for current bone graft technologies. 
One component necessary for bone tissue engineering is a 
readily available, osteogenic cell source. Human dermal 
fibroblasts may have the potential to differentiate along an 
osteoblastic lineage, making them a candidate for use in bone 
tissue engineering applications. The objective of this study was 
to validate the ability of dermal fibroblasts to express gene and 
protein markers of osteoblastic differentiation and to explore 
their potential, in combination with biomaterial scaffolds and 
signaling factors, for use in bone tissue engineering. 
I. INTRODUCTION 
HERE are over 600,000 bone graft procedures T performed in the United States each year[ 11. Autografts 
are used in approximately 90 percent of these surgeries, with 
natural and synthetic scaffolds accounting for the remaining 
10 percent[2]. While these methods are suitable for use in 
bone graft procedures, there are inherent limitations to their 
use, including limited supply, disease transmission, and 
inferior mechanical and biological properties. 
Bone tissue engineering using a combination of an 
osteogenic cell source, a biomaterial scaffold, and growth 
factors has the potential as a replacement for current graft 
materials[3]. Native osteoblasts are typically difficult to 
isolate and expand in vitro, which makes them less than 
ideal for bone tissue engineering applications[4]. One 
potential alternative source of cells that is non- 
immunogenic, easily expandable, and readily available 
through a minimally invasive harvesting procedure are 
dermal fibroblasts. Osteoinduction was first described by 
Marshall Urist as the ability of demineralized bone matrix to 
induce the osteoblastic differentiation of host fibroblasts[5]. 
Additionally the potential of fibroblasts to differentiate 
towards an osteoblastic lineage have been investigated[6- 
111. 
The objective of the following studies was to investigate 
the potential of human dermal fibroblasts, in combination 
with la,25-dihydroxyvitamin D3, as a source of cells for 
bone tissue engineering applications. 
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11. MATERIALS AND METHODS 
A .  Cell Culture 
Neonatal human dermal fibroblasts (Cascade Biologics, 
Portland, OR) were maintained in basal medium consisting 
of minimum essential medium (MEM) containing 10% fetal 
bovine serum (FBS), 100 U/ml penicillin, 100 pg/ml 
streptomycin, and 0.075% sodium bicarbonate and 
incubated at 37" C with 5% C02. 
1) Vitamin D Dose Dependence: Neonatal fibroblasts were 
plated at a density of 4500 cells/cm2 in 100-mm dishes in 
basal medium containing 1, 10, 100, and 1000 nM la,25- 
dihydroxyvitamin D3 (vitamin D) with 10 mM p- 
glycerophosphate (PGP) and 50 pgiml L-ascorbic acid. 
DMSO (0.02%) was added as a vehicle control. Alkaline 
phosphatase activity was quantified at 14 days. All further 
studies used 100 nM vitamin D. 
2) Monolayer Culture: Neonatal fibroblasts were 
trypsinized and plated on 100 mm dishes at a seeding 
density of 4500 cell/cm2 in basal serum-containing medium 
(S medium). Experimental cultures were plated in basal 
medium containing 100 nM vitamin D, 10 mM PGP, and 50 
pg/ml L-ascorbic acid (S+vitD medium). After 24 hours, all 
cultures were rinsed thoroughly with phosphate buffered 
saline (PBS) and the medium was replaced with chemically- 
defined medium in which 1 % insulin-transferrin-selenium 
(ITS) was substituted for serum (I and I+vitD medium). 
Fibroblast controls were maintained in S and S+vitD 
medium. Samples were analyzed at 7, 14, and 21 days for 
gene expression, biochemistry, and histology. 
3) Bone Morphogenetic Protein (BMP) Signaling: Cells 
were plated at a cell density of 10,000 celldm1 in 24 well 
plates in S or S+vitD medium. The recombinant BMP 
antagonist, noggin (R&D Systems, Minneapolis, MN), was 
added at a concentration of 0.1 pgiml to additional cultures 
maintained in S+vitD medium. After 24 hours, cultures were 
rinsed with PBS and experimental cultures were maintained 
in I+vitD medium with or without 0.1 pg/ml Noggin. 
Control cultures were maintained in S medium. At 3 and 14 
days, samples were taken for analysis of gene expression 
and biochemistry. 
4) Three-Dimensional Culture Seeding Densig: Dermal 
fibroblasts were seeded on 9-mm diameter, 3-mm thick 
ultraporous p-tricalcium phosphate (PTCP) scaffolds 
(Vitoss, Orthovita, Malvern, PA) at densities of 0.5, 1.5, 3.0, 
and 5.0 million cells/scaffold in 70 pl of S medium. Cells 
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were allowed to attach for 20 minutes and then flooded with 
either S or S+vitD medium. After 24 hours, scaffolds were 
rinsed with PBS and maintained in S, S+vitD, I, or I+vitD 
medium. Constructs were analyzed at 7, 14, 21, and 28 days 
for gene expression, biochemistry, and histology and 
immunochemistry. 
B. Gene Expression 
Total cellular RNA was extracted using the TRIzol 
isolation system (Invitrogen). Reverse transcription was 
performed using the Superscript First-Strand synthesis 
system for RT-PCR. Polymerase chain reactions for the 
monolayer study were carried out using TAQ DNA 
polymerase and oligonucleotide primers for human alkaline 
phosphatase[12], osteocalcin, osteopontin [ 111, and p- 
Actin[ 131. PCR products were resolved on a 1% agarose gel 
and analyzed by densitometry using Scion Image (Scion 
Corporation, Frederick, MD). Real-time PCR was performed 
in the BMP signaling and three-dimensional density 
dependence studies. Primers for alkaline phosphatase were 
as published[ 141. Osteocalcin primers and probes were 
purchased as a TAQMAN gene expression assay 
(Hs01587813-g1, Applied Biosystems) and BMP6 and 
GAPDH primers and probes were designed with Primer 
Express 3 .O software (Applied Biosystems). Real-time PCR 
reactions were performed with SYBR Green Master Mix or 
TAQMAN Master Mix (Applied Biosystems) using an 
Applied Biosystems 7300 real-time PCR system. Relative 
gene expression was determined using the AAC, method 
(Applied Biosystems User Bulletin #2). 
C. Biochemistry 
Protein and DNA were extracted with a 0.5% Triton-X 
100 in PBS. Samples cultured on P-TCP scaffolds required 
further extraction of DNA using 0.48 M sodium phosphate. 
Alkaline phosphatase activity was determined using a 
colorimetric assay (Sigma) in which p-nitrophenyl 
phosphate is cleaved to p-nitrophenol. The absorbance of the 
resulting product was read at 400 nm on a Biotek Synergy 
HT multidetection reader. 
Total DNA content was measured using the PicoGreen 
double-stranded DNA assay adapted for use in a microplate 
reader[l5]. 
D. Histology and Immunohistochemistry 
Samples were fixed with 10% neutral buffered formalin or 
4% paraformaldehyde. Three-dimensional scaffolds were 
dehydrated and embedded in paraffin. Serial 7-pm thick 
sections were processed for histological and 
Immunohistochemical analysis. Active alkaline phosphatase 
was localized by staining for 30 minutes with a Fast Blue 
RR-salt and Naphthol AS-MX phosphate dye (Sigma). 
Alexa Fluor 488-conjugated phalloidin (Molecular Probes) 
at a concentration of 5 unitdm1 was used to stain F-actin. 
Polyclonal antibodies for osteocalcin (V-19, Santa Cruz 
Biotechnology, Santa Cruz, CA) were used with a 
peroxidase-based detection system (Vectastain Elite ABC, 
Vector Labs, Burlingame, CA) and 3,3’ diaminobenzidine as 
the substrate chromagen to detect protein localization. Non- 
immune controls were performed without primary antibody. 
E. Statistical Analysis 
All data are presented as the mean * standard deviation. 
One- (vitamin D dose dependence), two-(monolayer and 
noggin studies), or three-way (density dependence study) 
ANOVAs with Tukey post-hoc tests were used to determine 
the effect of vitamin D dose dependence, culture medium, 
culture duration, and seeding density. Significance was set at 
p < 0.05. 
111. RESULTS 
1) Vitamin D Dose-Dependence: Expression of alkaline 
phosphatase activity normalized to DNA content showed a 
dose-dependent response to vitamin D. Significant increases 
in activity were observed when cells were cultured in the 
presence of 10 and 100 nM vitamin D, with maximal 
activity at 100 nM. Additionally, an increase in vitamin D to 
1000 nM resulted in a decrease in activity to a level similar 
to DMSO controls. 
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Fig. 1 : Ostcoblast-spccific gcnc cxprcssion by human dcrmal fibroblast 
cultures. Cells were cultured in S, S+vitD, I, or I+vitD medium. (A) 
Alkaline phosphatase, (C) osteocalcin, and (D) osteopontin gene expression 
were normalized to B-Actin. (€3) Alkaline phosphatase activity was 
nomalizcd to DNA content. (a: p<0.05 comparcd to S, I cultures, *: p<0.05 
compared to all culture conditions) 
2) Monolayer Culture: Human dermal fibroblasts plated 
in monolayer were analyzed at 7, 14, and 21 day time points 
for gene expression, biochemistry, and histology. Alkaline 
phosphatase, osteopontin, and osteocalcin were analyzed as 
markers of osteoblastic gene expression. Alkaline 
phosphatase (Fig 1A) was detected in all cultures with a 
significant up-regulation observed over time. There was no 
significant effect of culture medium on alkaline phosphatase 
expression. Osteocalcin (Fig IC) was only observed in 
cultures containing vitamin D, with a significant effect of 
both culture duration and culture medium. Osteocalcin 
expression was highest in cultures maintained in serum-free 
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medium with vitamin D, with maximum expression at 21 
days. Similar to osteocalcin, osteopontin (Fig 1D) was only 
observed in cultures supplemented with vitamin D. Maximal 
osteopontin expression was seen at 21 days. 
Alkaline phosphatase activity normalized to DNA content 
(Fig 1B) was elevated in monolayer cultures containing 
vitamin D at both 14 and 21 days. This increase was 
significantly greater in serum-free cultures compared to 
those containing serum. Alkaline phosphatase staining was 
observed in all cultures, with the highest levels of staining 
detected in fibroblasts maintained in the presence of vitamin 
D. However, a larger proportion of positively stained cells 
was seen in the serum-free cultures. Fibroblasts cultured in 
serum-free medium without supplements exhibited only 
slight staining. The alkaline phosphatase staining patterns 
were consistent with the activity data. Cellular morphology 
was assessed by staining F-actin. Cells cultured in serum- 
free medium with vitamin D exhibited a more polygonal 
shape, similar in shape to osteoblastic cells. The fibroblasts 
cultured in serum-containing medium and in serum-free 
medium without additional additives maintained an 
elongated, spindle-shaped morphology, typical of 
fibroblasts. 
Treatment with noggin caused a down-regulation of 
osteocalcin expression. BMP6 gene expression (Fig 2D) was 
also only seen in samples containing vitamin D. Treatment 
with noggin resulted in an increase in BMP6 gene 
expression. 
Alkaline phosphatase activity normalized to DNA content 
(Fig 2B) was observed at low levels at the 3 day time point. 
At 14 days, alkaline phosphatase activity was detected in all 
cultures, with a significant increase in activity in cultures 
containing vitamin D. Treatment with noggin resulted in a 
decrease in alkaline phosphatase activity by approximately 
47%. 
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Fig. 2: (A) Alkaline phosphatase, (C) osteocalcin, and (D) BMP6 gene 
expression and (B) alkaline phosphatase activity of human dermal 
fibroblasts maintained in S, I+vitD, or I+vitD+Noggin medium. Gene 
expression is shown relative to day 3 samples cultured in I+vitD medium. 
(a: p<0.05 compared to S cultures, *: p<0.05 compared to all culture 
conditions) 
3) BMP Signaling: Dermal fibroblasts cultured in 
monolayer and treated with noggin were analyzed at 3 and 
14 days for alkaline phosphatase, osteocalcin, and BMP6 
gene expression and alkaline phosphatase activity. Relative 
gene expression was normalized to GAPDH and expressed 
relative to the day 3 I+vitD samples. Alkaline phosphatase 
gene expression (Fig 2A) was significantly up-regulated in 
samples cultured with vitamin D, with decreased expression 
when cultured in the presence of noggin. Control samples 
exhibited low levels of expression of alkaline phosphatase. 
Osteocalcin gene expression (Fig 2C) was only observed in 
samples cultured in the presence of vitamin D at 14 days. 
Fig. 3: (A) Alkaline phosphatase and (C) ostcocalcin gene expression and 
(B) alkaline phosphatase activity of fibroblast-seeded scaffolds initially 
seeded with 1.5 or 3.0 x I O 6  cells and maintained in S or I+vitD medium. 
Gene expression is shown relative to day 7 samples cultured in I+vitD 
medium. (a: p<0.05 compared to S cultures, *: p<0.05 compared to all 
culture conditions) 
4) Three-Dimensional Culture Seeding Density: Analysis of 
21 day samples seeded with initial densities of 0.5, 1.5, 3, 
and 5 x lo6 cells showed osteoblastic gene expression only 
in scaffolds cultured in I+vitD medium. Alkaline 
phosphatase gene expression (normalized to GAPDH) was 
approximately 40% higher in scaffolds seeded with 0.5 and 
5.0 million cells compared to those seeded with 1.5 and 3 
million cells, with no difference between 1.5 and 3 million 
cells. Osteocalcin gene expression did not differ 
significantly between seeding densities. Alkaline 
phosphatase activity was significantly elevated in scaffolds 
seeded with 1.5 million cells compared to all other groups. 
DNA content was significantly increased in the scaffolds 
seeded at higher initial seeding densities (1.5, 3, and 5.0), 
with a maximum of approximately 800,000 attached cells at 
initial seeding densities of 3 and 5 million cells/scaffold. 
Taking into account gene expression, alkaline phosphatase 
activity, and DNA content, seeding densities of 1.5 and 3 
million cells were selected for further characterization. 
Scaffolds seeded with 1.5 and 3 x 1 O6 cells/scaffold were 
analyzed at 7, 14, 21, and 28 days. Alkaline phosphatase 
(Fig 3A) and osteocalcin (Fig 3C) gene expression were 
significantly higher in scaffolds cultured in I+vitD medium 
at all time points. There was no difference in gene 
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expression between scaffolds initially seeded with 1.5 and 
3.0 x 106 cells. Alkaline phosphatase activity (Fig 3B) was 
significantly increased in the scaffolds seeded at 1.5 x lo6 
cellsiscaffold at the 21 and 28 day time points. Staining for 
alkaline phosphatase and osteocalcin supported the gene 
expression and activity results, with the most intense 
staining in the scaffolds seeded at the lower initial density. 
IV. CONCLUSION 
These studies indicate that dermal fibroblasts cultured in 
chemically-defined medium supplemented with 1 a,25- 
dihydroxyvitamin D3 are able to express gene and protein 
markers consistent with an osteoblastic phenotype. This 
process appears to be partially blocked by noggin, indicating 
a role of bone morphogenetic proteins in the osteoblastic 
differentiation of these cells. Further studies are necessary to 
elucidate the exact role of BMPs in this process. Taken 
together, these results demonstrate that the combination of 
dermal fibroblasts, p-tricalcium phosphate scaffolds, and 
1 a,25-dihydroxyvitamin D3 has potential for use in bone 
tissue engineering applications. 
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